The following three tables show the number of prescription items dispensed in the community for the treatment of hepatitis B. The information is provided according to the individual British National Formulary (BNF) categories hepatitis B drugs fall within. Figures are split by strategic health authority (SHA) and presented in thousands. The data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.
Due to the disclosive nature of the data, it was not possible to present the data by type of drug. As such, data were aggregated to BNF category to maintain some measure of difference between drug type. The SHA totals may not match the England total due to rounding.
Thousand Number of prescription items used in the treatment of hepatitis B from BNF section 8.2.4, which were dispensed in the community in England from July 2003 to June 20081 SHA2,3 2003Jul-Dec 2004 2005 2006 2007 2008 Jan-Sep East Midlands 0.1 0.1 0.1 0.1 0.1 4— East of England 0.1 0.2 0.2 0.1 0.1 0.1 London 0.1 0.2 0.2 0.2 0.2 0.1 North East 4— 4— 4— 4— 4— 4— North West 0.2 0.2 0.3 0.2 0.2 0.2 South Central 0.1 0.1 0.2 0.1 0.1 0.1 South East Coast 0.2 0.3 0.2 0.1 0.1 0.1 South West 0.1 0.1 0.2 0.1 0.2 0.1 West Midlands 0.2 0.3 0.3 0.2 0.2 0.2 Yorkshire and the Humber 4— 0.1 0.1 0.1 0.1 0.1 England 1.0 1.7 1.7 1.3 1.3 0.9 1 Information at SHA level is only available for the past 60 months. 2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced. 3 The tables show drugs which may be used to treat hepatitis B, by SHA. 4 Indicates 50 or fewer items were dispensed during the period. Source: The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))
Thousand Number of prescription items used in the treatment of hepatitis B from BNF section 5.3.3, which were dispensed in the community in England from July 2003 to June 20081 SHA2,3 2003 Jul-Dec 2004 2005 2006 2007 2008 Jan-Sep East Midlands 4— 4— 4— 4— 0.1 0.1 East of England 4— 4— 0.1 4— 0.1 0.2 London 0.1 0.1 0.2 0.5 0.6 0.5 North East 4— 4— 4— 4— 4— 4— North West 4— 4— 4— 4— 0.1 0.1 South Central 4— 4— 4— 4— 0.1 0.1 South East Coast 4— 4— 0.1 0.1 0.1 0.1 South West 4— 4— 4— 0.1 0.1 0.1 West Midlands 4— 4— 4— 4— 0.1 0.1 Yorkshire and the Humber 4— 4— 4— 4— 0.1 0.2 England 0.1 0.3 0.5 0.9 1.5 1.4 1 Information at SHA level is only available for the past 60 months. 2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced. 3 The tables show drugs which may be used to treat hepatitis B, by SHA. 4 Indicates 50 or fewer items were dispensed during the period. Source The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))
Thousand Number of prescription items used in the treatment of hepatitis B from BNF section 5.3.1, which were dispensed in the community in England from July 2003 to June 20081 SHA2,3 2003 Jul-Dec 2004 2005 2006 2007 2008 Jan-Sep East Midlands 0.1 0.2 0.2 0.3 0.4 0.3 East of England 0.2 0.4 0.5 0.6 0.8 0.7 London 0.7 1.7 1.9 2.4 3 2.3 North East 0.1 0.2 0.2 0.3 0.2 0.1 North West 0.3 0.5 0.5 0.6 0.7 0.6 South Central 0.1 0.2 0.2 0.3 0.3 0.3 South East Coast 0.1 0.2 0.3 0.4 0.4 0.4 South West 0.1 0.2 0.3 0.4 0.4 0.3 West Midlands 0.3 0.6 0.6 0.7 0.7 0.6 Yorkshire and the Humber 0.1 0.3 0.3 0.4 0.5 0.4 England 2.0 4.5 5.1 6.4 7.4 6.0 1 Information at SHA level is only available for the past 60 months. 2 The data have been structured in line with current SHA arrangements. The structure changed during 2006 where the number of SHAs reduced. 3 The tables show drugs which may be used to treat hepatitis B, by SHA. Source: The Prescription Pricing Division of the NHS Business Services Authority (NHSBSA (PPD))
Data for notifications of hepatitis B by current and previous strategic health authorities (SHAs) are shown in the following table.
The Health Protection Agency Centre for Infections is not able to produce estimates of the prevalence of hepatitis B at SHA level.
Strategic health authority 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Current Previous East Midlands Leicestershire, Northants., Rutland 21 22 33 33 17 28 24 28 36 77 65 Trent 8 25 20 35 26 35 28 16 32 26 28 East of England Bedfordshire and Hertfordshire 15 13 24 38 48 66 51 59 59 14 8 Essex 6 4 3 7 8 6 3 — — 3 3 Norfolk, Suffolk and Cambridgeshire 4 8 19 17 3 5 9 12 17 8 7 London North Central London 30 55 37 39 30 27 44 27 16 24 28 North East London 30 30 57 50 43 36 18 23 10 20 11 North West London 10 13 14 27 19 13 21 11 8 11 8 South East London 87 87 101 92 149 162 157 174 209 171 111 South West London 12 16 13 11 9 14 5 8 6 7 8 North East County Durham and Tees Valley 7 6 11 30 55 37 23 13 23 53 13 Northumberland, Tyne and Wear 24 20 14 16 15 31 80 70 91 30 20 North West Cheshire and Merseyside 70 45 23 50 29 32 46 22 24 36 33 Cumbria and Lancashire 26 31 33 55 46 45 48 43 27 30 31 Greater Manchester 72 85 60 76 75 52 74 56 52 32 30 South Central Hampshire and Isle of Wight 5 14 6 2 6 14 32 52 58 64 78 Thames Valley 18 21 30 32 28 34 17 13 35 30 138 South East Coast Kent and Medway 6 23 16 27 37 20 25 23 28 10 18 Surrey and Sussex 48 37 34 51 40 27 14 24 34 26 39 South West Avon, Gloucestershire and Wiltshire 4 2 12 10 20 80 60 50 55 69 86 Dorset and Somerset 20 45 22 51 57 42 43 72 71 45 52 South West Peninsula 2 14 17 16 14 5 5 7 10 8 3 West Midlands Birmingham and the Black Country 18 21 25 21 14 35 33 100 109 56 45 Coventry, Warwicks., Herefords., Worcs. 9 8 5 7 5 14 22 12 10 10 32 Shropshire and Staffordshire 1 8 14 10 19 21 25 25 39 46 32 Yorkshire and Humberside North and East Yorkshire , N Lincolnshire 53 100 116 77 68 55 85 64 63 58 81 South Yorkshire 15 5 13 16 28 29 38 60 36 26 47 West Yorkshire 49 54 45 89 62 48 67 70 81 71 68 Port Health Authority — 1 — — — 1 — — — — — Total 670 813 817 985 970 1,014 1,097 1,134 1,239 1,061 1,123 Notes: 1. Hepatitis B is notifiable under the Public Health (Infectious Diseases) Regulations 1988. 2. Strategic health authorities have been merged, and the number reduced from 28 to 10. 3. Cells are left empty if no cases have been reported. 4. These data have already been published. Source: Health Protection Agency